Pharmaceutical Executive May 7, 2024
RxLink will incorporate Cost Plus’ prices into its drug pricing platform MedMap.
Mark Cuban’s Cost Plus Drug Company continues to expand its partnerships.
RxLink announced that it will be incorporating Cost Plus into its platform.1 MedMap, RxLink’s platform, allows users to use their insurance, third-party discount cards, and manufacturer offers to find and compare drug prices. According to a press release, the addition of Cost Plus to the platform has already accounted for over $162,000 in savings for customers.
In a press release, RxLink’s head of strategic partnerships JB Powell said, “(The relationship is) a natural way for two organizations committed to ensuring access to safe, affordable medicines to work together. There has never been a solution that allows patients...
Today's Sponsors
Today's Sponsor